Stanley-Laman Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$297K Sell
2025
Q1
$486K Buy
2024
Q4
Sell
2024
Q3
$203K Buy
2022
Q2
Sell
2022
Q1
$345K Buy
2021
Q1
Sell
2020
Q4
$512K Buy
2020
Q3
$328K Buy
2019
Q1
Sell
2018
Q4
$248K Buy